India’s largest pharmaceutical company, Sun Pharmaceutical Industries, reported a decline in its second-quarter net profit, mainly due to a one-time charge linked to its planned acquisition of Organon & Co. Net profit for the quarter ended September 30 fell to ₹19.89 billion from ₹31.18 billion in the same period last year. However, the company’s revenue Continue Reading
